AI Article Synopsis

Article Abstract

We have recently shown that the semi-continuous cultivation of a mouse hybridoma line in spinner flasks, with a basal defined medium (BDM) devoid of serum and protein, increases the secretion of the immunoreactive monoclonal antibody (MAb) by a factor of ca. 2.4, compared to culture in flasks with serum-containing medium (Schneider, 1989). To further optimise MAb production, we have now investigated the composition of BDM and the mode of cultivation. Hybridoma cells were inoculated at 0.3 x 10(6) cells/ml in 200 ml of BDM containing 4, 6 or 8 mM glutamine; after 3-4 days (when the cell density reached greater than or equal to 10(6) cells/ml) 20, 40, 60 or 100% of the culture medium were replaced daily by fresh nutritive BDM with or without 33, 66 or 100% cell recycling. Daily, over a total period of 15-16 days, viable cells were counted and the concentration of the MAb, of glucose and glutamine (the main nutrients) and of lactate, alanine and ammonia (the main metabolites) were assayed. These experiments indicate that to provide optimal cell growth and MAb production: (i) the concentration of glutamine in the nutritive medium should be maintained at 8 mM, otherwise it falls on some days to 0 with a significant amount of cell death; at 25 mM, glucose concentration is not a limiting factor, whatever the culture conditions; (ii) with a semi-continuous mode of cultivation, a perfusion rate of 40%/day appears optimal; without cell recycling, a rate of 20% does not provide enough nutrients and/or does not remove enough metabolites, whereas a rate of 60% washes over the cells; with cell recycling, rates of 60 (moderately) or 100% (considerably) increase cellular metabolism without concurrent augmentation of MAb secretion; (iii) the recycling of the cells increases the mean cell densities and the rate of production of the MAb, as well as the rate of consumption of nutrients and of production of metabolites; recycling of 33-66% is optimal, since the total recycling progressively raises the number of dead cells and debris; (iv) there are maximal values for cell densities (ca. 2.5 X 10(6) cells/ml) and MAb production (ca. 26 micrograms/10(6) cells X day) as well as for nutrient consumption and metabolite production (except with a very high perfusion rate).(ABSTRACT TRUNCATED AT 400 WORDS)

Download full-text PDF

Source
http://dx.doi.org/10.1016/0022-1759(90)90446-3DOI Listing

Publication Analysis

Top Keywords

mab production
12
106 cells/ml
12
cell recycling
12
cell
9
monoclonal antibody
8
culture conditions
8
cell growth
8
mode cultivation
8
optimal cell
8
cell densities
8

Similar Publications

Anti-programmed cell death 1 (PD-1) monoclonal antibodies (mAbs) have proven to be effective in treating various cancers, including colorectal, lung, and melanoma. Despite their clinical success, some patients develop resistance to mAbs, requiring co-treatments with radio- or chemotherapy. Interleukin-15 (IL-15) is an immunostimulatory cytokine that promotes immune cell production and proliferation.

View Article and Find Full Text PDF

Monoclonal antibodies (mAbs) are critical components in the therapeutic landscape, but their dosing strategies often evolve post-approval as new data emerge. This review evaluates post-marketing label changes in dosing information for FDA-approved mAbs from January 2015 to September 2024, with a focus on both initial and extended indications. We systematically analyzed dosing modifications, categorizing them into six predefined groups: Dose increases or decreases, inclusion of new patient populations by body weight or age, shifts from body weight-based dosing to fixed regimens, and adjustments in infusion rates.

View Article and Find Full Text PDF

Unlabelled: The choice of media and feeds significantly influences the performance of Chinese Hamster Ovary (CHO) mammalian cell cultures in producing desired biologics like monoclonal antibodies (mAb). Sub-optimal nutrient feed/media composition can severely impact cell proliferation and the quality of the final mAb product. For instance, proper protein glycosylation, crucial for mAb stability, safety, and efficacy, heavily relies on cell culture conditions.

View Article and Find Full Text PDF

Stability of complex biotherapeutics like monoclonal antibodies is paramount for their safe and efficacious use. Excipients are inactive ingredients that are added to the purified product so as to offer it a stable environment. Trehalose dihydrate is a non-reducing sugar that is commonly used as a stabilizing agent in biotherapeutic formulations under liquid and frozen states.

View Article and Find Full Text PDF

Protein A (ProA) affinity chromatography plays an essential role in purifying monoclonal antibodies (mAbs) and their analogues by reducing impurities like residual host cell proteins (HCPs), residual DNA, process additives, and potential viral contaminants. Decades of mAb process development and commercialization efforts have built extensive prior knowledge in the Protein A process. The prior knowledge facilities streamlined process development and minimized the need for extensive process characterization studies to inform manufacturing control strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!